Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection

Boehringer Ingelheim

Status

Conditions: HIV Infections

Treatments: Drug: Ritonavir; Drug: Tipranavir

Study type: Expanded Access

Funder types: Industry

Identifiers

NCT00097799

1182.70

Details and patient eligibility

About

This study was designed to provide early access to and evaluate the safety of TPV/r in PI-experienced patients with HIV-1 infection.

Sex

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria